Illumina Acquires GRAIL to Accelerate Patient Access to Life-Saving Multi-Cancer Early-Detection Test August 19, 2021
Clinical Validation of a Targeted Methylation-Based Multi-Cancer Early Detection Test Using an Independent Validation Set June 25, 2021
Grail Launches Long-Awaited Galleri Blood Test, its Groundbreaking Multi-Cancer Screening Diagnostic June 25, 2021
